EUVIMEDOdkrijte EUVIMED
Crossref

How effective is self‐management for men with lower urinary tract symptoms?

Nick Dunn, Alastair Lamb

Trends in Urology, Gynaecology & Sexual Health · 2009

DOI: 10.1002/tre.124 ↗

At a glance

Journal article in Trends in Urology, Gynaecology & Sexual Health, 2009. Written by Nick Dunn and 1 co-authors. 13 references.

PovzetekBibliografski podatkiCiteRelated studies

Abstract (original language)

Lower urinary tract symptoms (LUTS) in older men encompass frequency, hesitancy, low volume and poor stream. In most cases, the symptoms arise from benign prostatic hyperplasia, although other important causes should be considered, such as transitional cell carcinoma and neurodegenerative disorders. The symptoms can vary from mildly disabling to severely incapacitating, necessitating acute intervention (eg acute retention). This problem is common: about 50 per cent of men aged over 65 will suffer to the extent of adversely affecting their activities of daily living;1 30 per cent of men aged over 50 in the USA have moderate-to-severe symptoms.2 Before the 1980s, surgical prostatectomy dominated the choice of therapies for this problem. Indeed, to this day, there are absolute indications for surgical intervention, eg recurrent urinary tract infections, recurrent urinary retention and renal insufficiency.3 However, surgery has its limitations, and there are alternative strategies nowadays, notably medical intervention with drugs, which may accomplish relief of symptoms to an adequate extent. However, both of the two main drug groups – 5-alpha-reductase inhibitors and alpha blockers – have side-effects and in some men are not effective. In clinical trials, discontinuation rates of these drugs are high.4 It is likely that a substantial proportion of older men have always managed their urinary symptoms without recourse to a physician. They accept their symptoms as a part of ageing, alter their lifestyle, and put up with any inconvenience. However, with increasing awareness of prostate disease due to prostate cancer campaigns, patients are now more likely to seek medical advice when confronted with prostatic symptoms. In an ageing population, surgery later in life may be more hazardous,5 so it is pertinent to ask if self-management is a viable and safe option for LUTS. There is rather little evidence available on this subject. A review article in 2004 suggested that self-management strategies have 'little or no scientific evidence to support them, because effectiveness studies have not been performed'.6 In spite of this, self-management is recommended as a first intervention by the British Association of Urological Surgeons and the European Urology Association.7,8 The details of the strategies used to achieve self-management have been reported in two papers: a survey of the advice given by relevant health professionals who are dealing with the problem,9 and a consensus statement from multidisciplinary health professionals.10 There were 18 possible interventions. The most frequently used were educational (such as explaining the link between LUTS, the bladder and the prostate, and reassurance about no evidence of prostate cancer), fluid advice (such as total fluid restriction to less than two litres per 24 hours and caffeine avoidance), types of toileting (such as bladder retraining) and miscellaneous (such as urethral milking for terminal dribble). Such advice was most used by nurse continence advisers, and least by urologists. Health professionals tended to advise the use of either many of the 18 possible interventions or none or very few of them, ie there appeared to be no middle path. Although there is evidence supporting the use of some of these interventions individually, eg avoidance of caffeine,11 the effectiveness of the overall package was unknown until the report of a randomised controlled trial in 2007.12 This trial compared 73 men with LUTS on a self-management programme plus standard care with 67 men on standard care alone. Outcomes were measured up to 12 months after completion of the self-management programme. Standard care consisted of watchful waiting and medical and/or surgical intervention on a pragmatic basis. The self-management programme involved small-group educational sessions three times during the six weeks after the randomisation process. During these sessions, men learned about lifestyle modification (fluid management, avoidance of caffeine and use of alcohol) and behavioural changes (bladder retraining, double voiding and urethral milking). The results showed that men on the self-management programme did significantly better than those on standard care alone, in terms of treatment failure, eg urinary retention or use of drugs for control. For example, at 12 months 31 per cent of men on the self-management programme were classified as treatment failure compared with 79 per cent of those on the watchful-waiting programme; difference = 48 per cent (95 per cent CI 32–64 per cent). In terms of urinary symptoms, as measured on a validated scale (the International Prostate Symptom Score), at 12 months the mean score was 10.2 on the self-management programme versus 15.4 on standard care; difference = 5.1 (95 per cent CI 2.7–7.6 per cent). Reported in a separate paper,13 some (but not all) of objective frequency/volume chart measurements among the participants also showed statistically significant differences between the groups, favouring the self-management patients at 12 months. An example is that the mean voided volume and episodes of nocturia were both in favour of the self-management group, even though the total voided volume in 24 hours did not differ between the groups. This trial's results are impressively in favour of self-management. There are some caveats: only men of a certain motivation would elect to enter such a trial, and in fact men in the intervention arm were better educated than those in the watchful-waiting arm. Thus the results may not be generally applicable to all men. Equally, follow-up was only for a maximum of 12 months: the situation may well change further in time from the original intervention. Nonetheless, a further large-scale trial, set in the primary care environment, is surely warranted, with longer follow-up. Such a trial should ideally have four arms: self-management alone; drug therapy alone; self-management plus drug therapy; and watchful waiting. The results of such a trial have not been reported as yet. The main worry for patients with LUTS is often the possibility of prostate cancer. This needs to be excluded, as far as is possible, by means of a digital rectal examination and prostate-specific antigen measurement. Urinalysis should also be done. If all these tests are negative, the possibility of self-management for LUTS can be entertained. The choice of what to do should rest predominantly on the patient's shoulders, provided he is given adequate information and evidence to make a reasoned choice. Such evidence in favour of the self-management programme is now beginning to appear, but we must await the results of large community trials before we can definitively advise patients of the efficacy and safety of this method of treatment, which has many attractive aspects to it. Men also should understand that they must return to their physician if their symptoms worsen, and that in a small proportion, some form of intervention may be necessary at a later date.

Cite

APA

Dunn, N., & Lamb, A. (2009). How effective is self‐management for men with lower urinary tract symptoms?. Trends in Urology, Gynaecology & Sexual Health. https://doi.org/10.1002/tre.124

Vancouver

Dunn N, Lamb A. How effective is self‐management for men with lower urinary tract symptoms?. Trends in Urology, Gynaecology & Sexual Health. 2009. doi:10.1002/tre.124

BibTeX
@article{Dunn2009,
  author = {Dunn, Nick and Lamb, Alastair},
  title = {How effective is self‐management for men with lower urinary tract symptoms?},
  journal = {Trends in Urology, Gynaecology & Sexual Health},
  year = {2009},
  doi = {10.1002/tre.124}
}
Start for free →